Welcome to our dedicated page for MOBIX LABS SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Mobix Labs, Inc. reported sharply lower revenue and continued losses for the quarter ended March 31, 2026 while warning of substantial doubt about its ability to continue as a going concern. Quarterly net revenue was $970, down from $2,511 a year earlier, with a net loss of $5,853 compared with $2,291 in the prior-year period.
For the first six months of fiscal 2026, net revenue totaled $2,845 and the net loss was $15,978. Cash stood at $2,563 against total debt of $6,438, and net cash used in operations reached $9,017. The company improved its capital structure from a small equity deficit to positive stockholders’ equity of $8,845 through public equity offerings, ATM sales and exchanges of debt and payables into shares, but these transactions were dilutive to existing holders.
Management states that ongoing operating losses, negative operating cash flows and limited liquidity mean additional debt or equity financing is required to meet obligations over the next twelve months. Subsequent events include a 1‑for‑10 reverse stock split, full conversion of a $4,000 senior secured convertible note into 2,500,000 shares, and a new $2,400 Series A 10% Convertible Preferred Stock financing with attached purchase warrant, further emphasizing reliance on capital markets.
Mobix Labs, Inc. amended its senior secured convertible note with Leviston Resources on May 13, 2026, increasing the principal from $3 million to $4 million in exchange for an additional cash advance of $833,333.
The company also entered an Investor Rights Agreement giving Leviston the right, but not the obligation, over seven months to buy up to an additional $4.0 million of similar secured convertible notes. Between May 12 and May 18, 2026, Leviston converted the entire $4 million of principal plus accrued interest into 2,500,000 shares of Class A Common Stock, fully satisfying the note and terminating related agreements.
The share issuances relied on the Section 3(a)(9) exemption under the Securities Act, and Leviston’s beneficial ownership of Class A Common Stock did not exceed 4.99% at any time.
Mobix Labs, Inc. notified the SEC it cannot timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 under Rule 12b-25 because of accounting department turnover and the need for additional time to finalize its financial statements and disclosure controls. The company provided preliminary results: loss from operations of approximately $6.1 million, net revenues of approximately $970 thousand, and a net loss of approximately $5.9 million for the quarter ended March 31, 2026. The company stated its financial statements will continue to reflect substantial doubt about its ability to continue as a going concern for the next twelve months and expects to file the Form 10-Q within the extension period.
Mobix Labs, Inc. is registering the resale of up to 2,500,000 shares of Class A Common Stock, representing shares issuable upon conversion of a $3,000,000 senior secured convertible promissory note held by Leviston Resources, LLC. The company will receive no proceeds from these resales and the registration covers shares that would equal approximately 23.94% of outstanding Class A Common Stock as of April 16, 2026. The prospectus warns that the resale or market perception of these sales could materially depress the trading price of the Class A Common Stock.
LONG MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs, Inc. director Michael J. Long reported equity awards in the company’s Class A common stock. He received 14,805 shares on February 25, 2026 and an additional 5,000 shares on March 30, 2026, both recorded as grants or awards at a price of $0.00 per share.
After these transactions, Long directly owned 124,932 shares of Class A common stock. A footnote explains that an earlier grant of Restricted Stock Units was made on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership was adjusted for rounding following a 1-for-10 reverse stock split effective April 6, 2026.
Mobix Labs director Kurt Busch reported new equity awards in Mobix Labs, Inc. Class A Common Stock. He received 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026 as grant or award acquisitions at no stated purchase price.
After these awards, Busch directly owns 60,961 Class A shares. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030. Reported holdings reflect a 1-for-10 reverse stock split on April 6, 2026.
MOBIX Labs director and 10% owner James J. Peterson reported stock awards and updated holdings in the company’s shares. He received Class A Common Stock awards of 14,805 shares on February 25, 2026 and 5,000 shares on March 30, 2026, both at $0.00 per share as grants.
Following the latest award, he directly holds 325,462 shares of Class A Common Stock. Footnotes state these Restricted Stock Units were granted on February 25, 2026 and vested on April 1, 2026, and that his beneficial ownership figures were adjusted for a 1-for-10 reverse stock split effective April 6, 2026. He also holds Class B Common Stock convertible into 144,927 Class A shares at the holder’s option, plus fully vested options over 13,341 Class A shares at an exercise price of $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.
MOBIX LABS, INC director Frederick C. Goerner reported stock-based compensation awards rather than open‑market trades. He received grants of 14,805 and 5,000 shares of Class A Common Stock at a price of $0.00 per share, described as restricted stock units that were granted on February 25, 2026 and vested on April 1, 2026.
After these awards, he directly owns 172,057 shares of Class A Common Stock. He also holds Class B Common Stock convertible into 21,739 Class A shares at an exercise price of $0.00, plus fully vested options covering 13,341 shares at $68.40 per share and 2,000 shares at $41.80 per share.
ALDRICH DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Mobix Labs director David J. Aldrich reported equity awards in MOBX stock. He received grants of 14,805 shares of Class A Common Stock on February 25, 2026 and 5,000 shares on March 30, 2026, both at a stated price of $0.00 per share, reflecting compensation rather than open‑market purchases. Following these awards, he directly holds 52,693 Class A shares. Footnotes state the February 25, 2026 award consisted of Restricted Stock Units that vested on April 1, 2026, and that his beneficial ownership has been adjusted for a 1‑for‑10 reverse stock split effective April 6, 2026. He also holds fully vested options to buy 13,341 shares at $68.40 per share expiring on April 4, 2032 and 2,000 shares at $41.80 per share expiring on August 10, 2030.